Extrahepatic manifestations of chronic hepatitis B

Clinics in Liver Disease

Volumn 8, Issue 2, 2004, Pages 403-418

  Han, Steven Huy B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2A INTERFERON; ANTIVIRUS AGENT; CORTICOSTEROID; FAMCICLOVIR; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; PREDNISOLONE; VIDARABINE;

ARTHRITIS; CHRONIC HEPATITIS; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; ESSENTIAL MIXED CRYOGLOBULINEMIA; FOLLOW UP; GLOMERULONEPHRITIS; HEMODIALYSIS; HEPATITIS B; HUMAN; LONG TERM CARE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MORTALITY; PATHOGENESIS; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; POLYARTERITIS NODOSA; POLYMYOSITIS; PREVALENCE; PROGNOSIS; PROLIFERATIVE GLOMERULONEPHRITIS; REVIEW; SERUM SICKNESS; SKIN MANIFESTATION; TREATMENT FAILURE; TREATMENT OUTCOME;

ARTHRALGIA; CHILD; CRYOGLOBULINEMIA; GLOMERULONEPHRITIS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; POLYARTERITIS NODOSA; PURPURA; SERUM SICKNESS;

EID: 2942620400     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2004.02.003     Document Type: Review

References (93)

1. Lee W.M. Hepatitis B virus infection. N Engl J Med. 337:1997;1733-1745
2. Lok A.S., McMahon B.J. Chronic hepatitis B. Hepatology. 34:2001;1225-1241
3. Lok A.S., Heathcote E.J., Hoofnagle J.H. Management of hepatitis B: 2000-summary of a workshop. Gastroenterology. 120:2001;1828-1853
4. Maddrey W.C. Hepatitis B: an important public health issue. J Med Virol. 61:2000;362-366
5. Willson R.A. Extrahepatic manifestations of chronic viral hepatitis. Am J Gastroenterol. 92:1997;3-17
6. Czaja A.J., Carpenter H.A., Santrach P.J., Moore S.B. Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology. 108:1995;157-164
7. Gocke D.J., Hsu K., Morgan C., Bombardieri S., Lockshin M., Christian C.L. Association between polyarteritis and Australia antigen. Lancet. 2:1970;1149-1153
8. Trepo C., Thivolet J. Hepatitis associated antigen and periarteritis nodosa (PAN). Vox Sang. 19:1970;410-411
9. Drueke T., Barbanel C., Jungers P., Digeon M., Poisson M., Brivet F., et al. Hepatitis B antigen-associated periarteritis nodosa in patients undergoing long-term hemodialysis. Am J Med. 68:1980;86-90
10. McMahon B.J., Heyward W.L., Templin D.W., Clement D., Lanier A.P. Hepatitis B-associated polyarteritis nodosa in Alaskan Eskimos: clinical and epidemiologic features and long-term follow-up. Hepatology. 9:1989;97-101
11. Trepo C.G., Zucherman A.J., Bird R.C., Prince A.M. The role of circulating hepatitis B antigen/antibody immune complexes in the pathogenesis of vascular and hepatic manifestations in polyarteritis nodosa. J Clin Pathol. 27:1974;863-868
12. Guillevin L., Lhote F., Cohen P., Sauvaget F., Jarrousse B., Lortholary O., et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore). 74:1995;238-253
13. Dienstag J.L. Immunopathogenesis of the extrahepatic manifestations of hepatitis B virus infection. Springer Semin Immunopathol. 3:1981;461-472
14. Marcellin P., Calmus Y., Takahashi H., Zignego A.L., Chatenoud L., Galanaud L.P., et al. Latent hepatitis B virus (HBV) infection in systemic necrotizing vasculitis. Clin Exp Rheumatol. 9:1991;23-28
15. Chan G., Kowdley K.V. Extrahepatic manifestations of chronic viral hepatitis. Compr Ther. 21:1995;200-205
16. Trepo C., Guillevin L. Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis. J Autoimmun. 16:2001;269-274
17. Sergent J.S., Lockshin M.D., Christian C.L., Gocke D.J. Vasculitis with hepatitis B antigenemia: long-term observation in nine patients. Medicine (Baltimore). 55:1976;1-18
18. Duffy J., Lidsky M.D., Sharp J.T., Davis J.S., Person D.A., Hollinger F.B., et al. Polyarthritis, polyarteritis and hepatitis B. Medicine (Baltimore). 55:1976;19-37
19. Shusterman N., London W.T. Hepatitis B and immune-complex disease. N Engl J Med. 310:1984;43-46
20. McElgunn P.S. Dermatologic manifestations of hepatitis B virus infection. J Am Acad Dermatol. 8:1983;539-548
21. Sergent J.S. Extrahepatic manifestations of hepatitis B infection. Bull Rheum Dis. 33:1983;1-6
22. Guillevin L., Visser H., Noel L.H., Pourrat J., Vernier I., Gayraud M., et al. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome-62 patients. J Rheumatol. 20:1993;1345-1349
23. Rogers R.B., Smith J.G. Jr., Chalker D.K. Hepatitis and the skin. J Am Acad Dermatol. 7:1982;552-554
24. Gower R.G., Sausker W.F., Kohler P.F., Thorne G.E., McIntosh R.M. Small vessel vasculitis caused by hepatitis B virus immune complexes. Small vessel vasculitis and HBsAG. J Allergy Clin Immunol. 62:1978;222-228
25. Fye K.H., Becker M.J., Theofilopoulos A.N., Moutsopoulos H., Feldman J.L., Talal N. Immune complexes in hepatitis B antigen-associated periarteritis nodosa. Detection by antibody-dependent cell-mediated cytotoxicity and the Raji cell assay. Am J Med. 62:1977;783-791
26. Michalak T. Immune complexes of hepatitis B surface antigen in the pathogenesis of periarteritis nodosa. A study of seven necropsy cases. Am J Pathol. 90:1978;619-632
27. Mirise R.T., Kitridou R.C. Arthritis and hepatitis. West J Med. 130:1979;12-17
28. Wartelle-Bladou C., Lafon J., Trepo C., Pichoud C., Picon M., Pellissier J.F., et al. Successful combination therapy of polyarteritis nodosa associated with a pre-core promoter mutant hepatitis B virus infection. J Hepatol. 34:2001;774-779
29. Miguelez M., Bueno J., Laynez P. Polyarteritis nodosa associated with precore mutant hepatitis B virus infection. Ann Rheum Dis. 57:1998;173
30. Pear B.L. Radiologic recognition of extrahepatic manifestations of hepatitis B antigenemia. Am J Roentgenol. 137:1981;135-140
31. Lam K.C., Lai C.L., Trepo C., Wu P.C. Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med. 304:1981;380-386
32. Guillevin L., Jarrousse B., Lok C., Lhote F., Jais J.P., Thi Huong D.D., et al. Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. The Cooperative Study Group for Polyarteritis Nodosa. J Rheumatol. 18:1991;567-574
33. Pinto P.C., Hu E., Bernstein-Singer M., Pinter-Brown L., Govindarajan S. Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis B. Cancer. 65:1990;878-884
34. Yoshiba M., Sekiyama K., Iwabuchi S., Takatori M., Tanaka Y., Uchikoshi T., et al. Recurrent fulminant hepatic failure in an HB carrier after intensive chemotherapy. Dig Dis Sci. 38:1993;1751-1755
35. Simsek H., Telatar H. Successful treatment of hepatitis B virus-associated polyarteritis nodosa by interferon alpha alone. J Clin Gastroenterol. 20:1995;263-265
36. Avsar E., Savas B., Tozun N., Ulusoy N.B., Kalayci C. Successful treatment of polyarteritis nodosa related to hepatitis B virus with interferon alpha as first-line therapy. J Hepatol. 28:1998;525-526
37. Guillevin L., Lhote F., Sauvaget F., Deblois P., Rossi F., Levallois D., et al. Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges. Ann Rheum Dis. 53:1994;334-337
38. Guillevin L., Lhote F., Leon A., Fauvelle F., Vivitski L., Trepo C. Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients. J Rheumatol. 20:1993;289-298
39. Gupta S., Piraka C., Jaffe M. Lamivudine in the treatment of polyarteritis nodosa associated with acute hepatitis B. N Engl J Med. 344:2001;1645-1646
40. Kruger M., Boker K.H., Zeidler H., Manns M.P. Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b. J Hepatol. 26:1997;935-939
41. Wicki J., Olivieri J., Pizzolato G., Sarasin F., Guillevin L., Dayer J.M., et al. Successful treatment of polyarteritis nodosa related to hepatitis B virus with a combination of lamivudine and interferon alpha. Rheumatology (Oxford). 38:1999;183-185
42. Erhardt A., Sagir A., Guillevin L., Neuen-Jacob E., Haussinger D. Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha-interferon and lamivudine. J Hepatol. 33:2000;677-683
43. Combes B., Shorey J., Barrera A., Stastny P., Eigenbrodt E.H., Hull A.R., et al. Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet. 2:1971;234-237
44. Brzosko W.J., Krawczynski K., Nazarewicz T., Morzycka M., Nowoslawski A. Glomerulonephritis associated with hepatitis-B surface antigen immune complexes in children. Lancet. 2:1974;477-482
45. Kohler P.F., Cronin R.E., Hammond W.S., Olin D., Carr R.I. Chronic membranous glomerulonephritis caused by hepatitis B antigen-antibody immune complexes. Ann Intern Med. 81:1974;448-451
46. Lai K.N., Li P.K., Lui S.F., Au T.C., Tam J.S., Tong K.L., et al. Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med. 324:1991;1457-1463
47. Knieser M.R., Jenis E.H., Lowenthal D.T., Bancroft W.H., Burns W., Shalhoub R. Pathogenesis of renal disease associated with viral hepatitis. Arch Pathol. 97:1974;193-200
48. Ozawa T., Levisohn P., Orsini E., McIntosh R.M. Acute immune complex disease associated with hepatitis. Etiopathogenic and immunopathologic studies of the renal lesion. Arch Pathol Lab Med. 100:1976;484-486
49. Hirose H., Udo K., Kojima M., Takahashi Y., Miyakawa Y., Miyamoto K., et al. Deposition of hepatitis B e antigen in membranous glomerulonephritis: identification by F(ab')2 fragments of monoclonal antibody. Kidney Int. 26:1984;338-341
50. Lai K.N., Lai F.M., Lo S., Ho C.P., Chan K.W. IgA nephropathy associated with hepatitis B virus antigenemia. Nephron. 47:1987;141-143
51. Nagy J., Bajtai G., Brasch H., Sule T., Ambrus M., Deak G., et al. The role of hepatitis B surface antigen in the pathogenesis of glomerulopathies. Clin Nephrol. 12:1979;109-116
52. Takekoshi Y., Tanaka M., Miyakawa Y., Yoshizawa H., Takahashi K., Mayumi M. Free "small" and IgG-associated "large" hepatitis B e antigen in the serum and glomerular capillary walls of two patients with membranous glomerulonephritis. N Engl J Med. 300:1979;814-819
53. Chung D.R., Yang W.S., Kim S.B., Yu E., Chung Y.H., Lee Y., et al. Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon. Am J Nephrol. 17:1997;112-117
54. Wong S.N., Yu E.C., Chan K.W. Hepatitis B virus associated membranous glomerulonephritis in children-experience in Hong Kong. Clin Nephrol. 40:1993;142-147
55. Yoshikawa N., Ito H., Yamada Y., Hashimoto H., Katayama Y., Matsuyama S., et al. Membranous glomerulonephritis associated with hepatitis B antigen in children: a comparison with idiopathic membranous glomerulonephritis. Clin Nephrol. 23:1985;28-34
56. Wiggelinkhuizen J., Sinclair-Smith C., Stannard L.M., Smuts H. Hepatitis B virus associated membranous glomerulonephritis. Arch Dis Child. 58:1983;488-496
57. Hepatitis B surface antigenemia in North American children with membranous glomerulonephropathy. Southwest Pediatric Nephrology Study Group. J Pediatr. 106:1985;571-578
58. Morzycka M., Slusarczyk J. Kidney glomerular pathology in various forms of acute and chronic hepatitis. Arch Pathol Lab Med. 103:1979;38-41
59. L'Abbate A., Bartolomeo F., Misefari V., Martorano C., Maggiore Q. HBsAg immune complex glomerulonephritis. Proc Eur Dial Transpl Assoc. 15:1978;473-479
60. Johnson R.J., Couser W.G. Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int. 37:1990;663-676
61. Venkataseshan V.S., Lieberman K., Kim D.U., Thung S.N., Dikman S., D'Agati V., et al. Hepatitis-B-associated glomerulonephritis: pathology, pathogenesis, and clinical course. Medicine (Baltimore). 69:1990;200-216
62. Nowoslawski A. Hepatitis B virus-induced immune complex disease. Prog Liver Dis. 6:1979;393-406
63. Lai K.N., Tam J.S., Lin H.J., Lai F.M. The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia. Nephron. 54:1990;12-17
64. Garcia G., Scullard G., Smith C., Weissberg J., Alexander S., Robinson W.S., et al. Preliminary observation of hepatitis B-associated membranous glomerulonephritis treated with leukocyte interferon. Hepatology. 5:1985;317-320
65. Mizushima N., Kanai K., Matsuda H., Matsumoto M., Tamakoshi K., Ishii H., et al. Improvement of proteinuria in a case of hepatitis B-associated glomerulonephritis after treatment with interferon. Gastroenterology. 92:1987;524-526
66. De Man R.A., Schalm S.W., van der Heijden A.J., ten Kate F.W., Wolff E.D., Heijtink R.A. Improvement of hepatitis B-associated glomerulonephritis after antiviral combination therapy. J Hepatol. 8:1989;367-372
67. Wong S.N., Yu E.C., Lok A.S., Chan K.W., Lau Y.L. Interferon treatment for hepatitis B-associated membranous glomerulonephritis in two Chinese children. Pediatr Nephrol. 6:1992;417-420
68. Giboa N., Neigut D. Interferon treatment of hepatitis B-associated membranous glomerulonephritis and nephrotic syndrome. Pediatr Nephrol. 7:1993;328-329
69. Lisker-Melman M., Webb D., Di Bisceglie A.M., Kassianides C., Martin P., Rustgi V., et al. Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon. Ann Intern Med. 111:1989;479-483
70. Conjeevaram H.S., Hoofnagle J.H., Austin H.A., Park Y., Fried M.W., Di Bisceglie A.M. Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa. Gastroenterology. 109:1995;540-546
71. Lin C.Y. Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon. Kidney Int. 47:1995;225-230
72. Gocke D.J. Extrahepatic manifestations of viral hepatitis. Am J Med Sci. 270:1975;49-52
73. Weiss T.D., Tsai C.C., Baldassare A.R., Zuckner J. Skin lesions in viral hepatitis: histologic and immunofluorescent findings. Am J Med. 64:1978;269-273
74. Onion D.K., Crumpacker C.S., Gilliland B.C. Arthritis of hepatitis associated with Australia antigen. Ann Intern Med. 75:1971;29-33
75. Alpert E., Isselbacher K.J., Schur P.H. The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies. N Engl J Med. 285:1971;185-189
76. Wands J.R., Alpert E., Isselbacher K.J. Arthritis associated with chronic active hepatitis: complement activation and characterization of circulating immune complexes. Gastroenterology. 69:1975;1286-1291
77. Schumacher H.R., Gall E.P. Arthritis in acute hepatitis and chronic active hepatitis. Pathology of the synovial membrane with evidence for the presence of Australia antigen in synovial membranes. Am J Med. 57:1974;655-664
78. Popp J.W. Jr., Harrist T.J., Dienstag J.L., Bhan A.K., Wands J.R., LaMont J.T., et al. Cutaneous vasculitis associated with acute and chronic hepatitis. Arch Intern Med. 141:1981;623-629
79. Dienstag J.L., Rhodes A.R., Bhan A.K., Dvorak A.M., Mihm M.C. Jr., Wands J.R. Urticaria associated with acute viral hepatitis type B: studies of pathogenesis. Ann Intern Med. 89:1978;34-40
80. Gammon W.R., Wheeler C.E. Jr. Urticarial vasculitis: report of a case and review of the literature. Arch Dermatol. 115:1979;76-80
81. Ljunggren B., Moller H. Hepatitis presenting as transient urticaria. Acta Derm Venereol. 51:1971;295-297
82. Lockshin N.A., Hurley H. Urticaria as a sign of viral hepatitis. Arch Dermatol. 105:1972;570-571
83. Levo Y., Gorevic P.D., Kassab H.J., Zucker-Franklin D., Franklin E.C. Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med. 296:1977;1501-1504
84. Realdi G., Alberti A., Rigoli A., Tremolada F. Immune-complexes and Australia antigen in cryoglobulinemic sera. Z Immunitatsforsch Exp Klin Immunol. 147:1974;114-126
85. Dienstag J.L., Wands J.R., Isselbacher K.J. Hepatitis B and essential mixed cryoglobulinemia. N Engl J Med. 297:1977;946-947
86. Popp J.W. Jr., Dienstag J.L., Wands J.R., Bloch K.J. Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection. Ann Intern Med. 92:1980;379-383
87. Lunel F., Musset L., Cacoub P., Frangeul L., Cresta P., Perrin M., et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology. 106:1994;1291-1300
88. Gianotti F. Papular acrodermatitis of childhood. An Australia antigen disease. Arch Dis Child. 48:1973;794-799
89. Bacon P.A., Doherty S.M., Zuckerman A.J. Hepatitis-B antibody in polymalgia Rheumatica. Lancet. 2:1975;476-478
90. Pittsley R.A., Shearn M.A., Kaufman L. Acute hepatitis B simulating dermatomyositis. JAMA. 239:1978;959
91. Mihas A.A., Kirby J.D., Kent S.P. Hepatitis B antigen and polymyositis. JAMA. 239:1978;221-222
92. Farivar M., Wands J.R., Benson G.D., Dienstag J.L., Isselbacher K.J. Cryoprotein complexes and peripheral neuropathy in a patient with chronic active hepatitis. Gastroenterology. 71:1976;490-493
93. Niermeijer P., Gips C.H. Guillain-Barre syndrome in acute HBs Ag-positive hepatitis. BMJ. 4:1975;732-733